Filing Details

Accession Number:
0001193805-14-001950
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-09 11:11:20
Reporting Period:
2014-10-01
Filing Date:
2014-10-09
Accepted Time:
2014-10-09 11:11:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438533 Retrophin Inc. RTRX Pharmaceutical Preparations (2834) 262383102
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1525354 Martin Shkreli C/O Retrophin, Inc.
777 Third Avenue, 22Nd Floor
New York NY 10017
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-01 25,000 $8.11 2,962,168 No 4 P Direct
Common Stock Disposition 2014-10-01 300,000 $0.01 2,662,168 No 4 S Direct
Common Stock Acquisiton 2014-10-02 332,980 $0.00 2,995,148 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 S Direct
No 4 J Direct
Footnotes
  1. The reporting person previously agreed to sell 300,000 shares of common stock to an unaffiliated person for a purchase price of $0.01 per share following the occurrence of certain events.
  2. In November 2012, the reporting person pledged a gift of 66,596 shares of common stock of Retrophin, Inc. (which entity was subsequently acquired by the Issuer) to an unaffiliated third party who was the potential recipient. Such shares were subsequently exchanged for 332,980 shares of common stock of the Issuer in connection with the acquisition of Retrophin, Inc. by the Issuer in December 2012. On October 2, 2014, the reporting person and the potential recipient determined to rescind the gift because the potential recipient declined to accept such pledged shares.